renin-angiotensin system inhibitorsodium-glucose 2 inhibitorbeta-blockermineralocorticoid receptor antagonistheart failureHFrEFHFpEFESC
…ciety of Cardiology (ESC) 2021 guidelines, which consisted of a renin-angiotensin system inhibitor, a beta-blocker, a mineralocorticoid receptor antagonist and a …